Covid-19 and Influenza Oral Vaccine Study

Clinical trial NCT06355232 · RECRUITING

Trial details

NCT number: NCT06355232
Sponsor: Vaxine Pty Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

covid19 Infection Influenza, Human

Start date: 2024-05-01
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.